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Despite a century of intensive investigation the effective treatment of protein aggregation
diseases remains elusive. Ordinarily, molecular chaperones ensure that proteins maintain
their functional conformation. The appearance of misfolded proteins that aggregate implies
the collapse of the cellular chaperone quality control network. That said, the cellular
chaperone network is extensive and functional information regarding the detailed action
of specific chaperones is not yet available. J proteins (DnaJ/Hsp40) are a family of
chaperone cofactors that harness Hsc70 (heat shock cognate protein of 70 kDa) for diverse
conformational cellular tasks and, as such, represent novel clinically relevant targets for
diseases resulting from the disruption of proteostasis. Here we review incisive reports
identifying mutations in individual J protein chaperones and the proteostasis collapse that
ensues.
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J PROTEINS: PERSONAL TRAVEL GUIDES
In neurons, there are significant demands on cellular folding
events. Dynamic protein complexes are central to synaptic
transmission, a process that occurs with speed, precision and
plasticity. Most proteins can exist in more than one confor-
mation and many proteins must change conformation and
activity regularly. Rigorous quality control mechanisms oper-
ate at the synapse to provide defense against the detrimental
effects of functionally impaired proteins and protein complexes.
The balance between protecting protein functional integrity
and preventing accumulation of misfolded proteins is accom-
plished by a network of chaperone families including: J pro-
teins (DnaJ/Hsp40), HspA (Hsp70), HspB (small Hsp) HspC
(Hsp90), HspD/E (Hsp60/Hsp10), HspH (Hsp110), CCT (TRiC)
and numerous regulatory factors (Figure 1). Operating like
a switch, J proteins control Hsc70 (70–kDa heat shock cog-
nate protein) by directing and activating Hsc70’s ATPase activ-
ity for conformational and refolding work (Kampinga and
Craig, 2010; Kakkar et al., 2012). Sequence analysis has high-
lighted the diversity of the J protein family but has not pro-
vided much clarity into the functionality of specific J proteins.
Each J protein has a 70 amino acid signature region com-
prised of four helices, called a J domain. Outside of the J
domain, J proteins are structurally divergent, likely the basis for
their distinct functional properties. Originally named Hsp40 or
DnaJ after the founding members of the family (Georgopoulos
et al., 1980; Ohtsuka et al., 1990), we now know that there
are 49 J proteins in humans that range in molecular weight
from 18–520 kDa and that while some J proteins are induced
by heat most members of the J protein family are consti-
tutively expressed (Zhao et al., 2008; Kakkar et al., 2012).
The recognition that Hsc70 serves as a central hub and J
proteins are the switches for diverse proteostasis events has
fueled investigations into understanding the specific role of J
proteins.
AGE-ASSOCIATED NEURODEGENERATIVE DISORDERS
How do folding processes go awry in age? To counteract aging
and disease, neurons must routinely regulate protein machinery
within tight limits. The quality control machinery constantly
protects against the misfolding and aggregation of proteins that
is inherent to continuous protein synthesis, generation of fold-
ing intermediates and molecular crowding of neural proteins.
Neurons which don’t undergo cell division are vulnerable to
infectious misfolded aggregated proteins that spread (e.g., prion
diseases), mutations that produce toxic proteins characteristic of
late onset of neurodegenerative disorders such as Alzheimer’s dis-
ease, Parkinson’s disease, Huntington’s disease, and Amyotrophic
Lateral Sclerosis (ALS) as well as mutations that generate ineffec-
tive chaperones. In fact, at the cellular level, pathology may start
long before the onset of clinical symptoms associated with failure
of the chaperone machinery to meet the demands of misfolded
proteins. While it is widely accepted that J proteins maintain
and restore protein balance several questions remain regarding
the nature of changes to the chaperone network in age related
neurodegenerative diseases (Soti and Csermely, 2002; Muchowski
and Wacker, 2005; Kim et al., 2013; Labbadia and Morimoto,
2014).
DEFINING A TRAJECTORY TO UNDERSTAND THE FUNCTION
OF SPECIFIC J PROTEINS
The chaperone network is elaborate and elucidating the function
of individual J proteins is challenging. Chaperonopathies are a
collection of diseases caused by genetically inherited mutations
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FIGURE 1 | Disease modifying pathways of select J proteins.
in chaperones. Our growing appreciation that diverse diseases in
humans result from select J protein mutations provides new roads
to explore the mechanisms of action of individual J proteins. To
date, mutations in seven distinct J proteins; DNAJB2, DNAJB6,
DNAJC5, DNAJC6, DNAJC13, DNAJC19 and DNAJC29 have
been linked to distinct diseases in humans (Table 1). Here we
review the information that these recently identified mutations
provide regarding individual J protein function and the col-
lapse of proteostasis. Understanding the mechanisms of specific
J proteins is key to understanding the proteostasis machin-
ery and will be critically important for J protein-based drug
development.
DNAJB2 (HSJ1)
Mutation of DNAJB2 (HSJ1), a 32/38 kDa J protein, causes reces-
sive distal hereditary motor neuropathy (Blumen et al., 2012).
Originally identified in Morocco, individuals show a distal motor
weakness, hypotonia, atrophy and paralysis of the lower limbs
in young adulthood (age 20) due to progressive degeneration of
motor neurons in the spinal cord.
HSJ1 was first identified via expression cloning with antiserum
prepared against Alzheimer’s disease brain extracts enriched in
helical filaments (Cheetham et al., 1992). It is preferentially
expressed in neurons where it is proposed to promote proteasome
degradation of proteins tagged with polyubiquitin (Cheetham
et al., 1992; Chapple and Cheetham, 2003; Westhoff et al., 2005;
Howarth et al., 2007). Alternative splicing produces two isoforms.
HSJ1a is a cytosolic 32 kDa form and HSJ1b is a 38 kDa form
that is anchored to the cytosolic face of the endoplasmic retic-
ulum via C terminal geranylgeranylation. In addition to its J
domain, HSJ1 contains two unique ubiquitin interaction domains
that bind ubiquitin to prevent aggregation and direct ubiqui-
tinated/misfolded proteins to the proteasome. Which misfolded
proteins are targeted by HSJ1? In cellular models HSJ1a suppresses
the aggregation of polyglutamine expanded proteins and mutant
superoxide dismutatse1 (SOD1; Chapple et al., 2004; Westhoff
et al., 2005; Gao et al., 2011; Blumen et al., 2012). Transgene
upregulation of HSJ1a reduces brain huntingtin aggregation in
the mouse R6/2 model of Huntington’s disease (Labbadia et al.,
2012) and mutant SOD1 aggregation in the mouse SOD1G93A
model of ALS (Novoselov et al., 2013). Key questions arise from
these findings. While transgenic expression of HSJ1 alone reduces
aggregation, it does not fully reverse disease progression and
correct life span. Whether reinforcing other J proteins along with
HSJ1 will completely circumvent the cascade of degeneration
remains an open question. Further, while the splice mutation
that give rise to distal motor neuropathy in humans decreases
the availability of both HSJ1a and HSJ1b which are broadly
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Table 1 | J proteins mutations and resulting proteostasis consequences in human diseases.
Human disease Chaperone Mutation References
Autosomal-recessive distal
hereditary motor
neuropathy
DNAJB2
(HSJ1)
32 kda (cytosolic) HSJ1a
38 kda (endoplasmic
reticulum) HSJ1b
Splice mutation (Blumen et al., 2012)
Autosomal-dominant limb-grid
muscular dystrophy
DNAJB6
(Mrj)
26 kda
Phe93Leu
Phe89Ile
Pro96Arg
Splice mutation
(Harms et al., 2012;
Sarparanta et al., 2012;
Sato et al., 2013;
Suarez-Cedeno et al., 2014)
Adult onset autosomal-
dominant, neuronal ceroid
lipofusinosis (ANCL)
DNAJC5
(CSPα)
35 kda
Leu115Arg
Leu116del
(Benitez et al., 2011;
Nosková et al., 2011;
Velinov et al., 2012)
Autosomal-recessive
juvenile parkinsonism
DNAJC6
(Auxilin)
100 kda
80 kb deletion
(Exons 5–19)
Gln734X
Splice mutation
(Edvardson et al., 2012;
Vauthier et al., 2012;
Körog˘lu et al., 2013)
Adult onset autosomal-
dominant Parkinson’s
disease
DNAJC13
(RME-8)
220 kda
Asn855Ser (Vilariño-Güell et al., 2014)
Autosomal-recessive
dilated cardiomyopathy
(DCMA) and cerebellar
ataxia
DNAJC19
(TIM14)
18 kda
Single nucleotide deletion
Frameshift mutation
(Davey et al., 2006;
Ojala et al., 2012)
Autosomal-recessive
spastic ataxia of
Charlevoix-Saguenay
(ARSACS)
DNAJC29
(Sacsin)
521 kda
Asp168Tyr
Leu308Phe
Leu556Pro
(>100 mutations)
(Bouchard et al., 1978;
Engert et al., 2000;
Thiffault et al., 2013)
expressed in neurons, the mutation causes selective loss of motor
neuron function. Obviously, whether HSJ1 has a motor neuron
specific or a general neuronal function will be the focus of future
investigation.
DNAJB6 (Mrj)
Mutations in DnaJB6 (Mrj; mammalian relative of DnaJ), a
26/36 kDa J protein cause autosomal dominant limb-girdle mus-
cular dystrophy type 1 D (Harms et al., 2012; Sarparanta et al.,
2012; Sato et al., 2013; Suarez-Cedeno et al., 2014). Four muta-
tions F96L, F96I, F89I and F93L results in adult or child onset
(age 14–68 yrs) limb-girdle muscular dystrophy type 1D which is
clinically characterized by elevated serum creatine kinase levels,
progressive muscle weakness mainly in the legs. Limb-girdle mus-
cular dystrophies are a heterogeneous group of inherited disorders
caused by a number of dominant or recessive mutations that cause
myofibrillar myopathy and the DNAJB6 mutations are specifically
distinguished by characteristic protein aggregates and autophagic
vacuoles (Mitsuhashi and Kang, 2012).
Mrj is a ubiquitous J protein with Hsc70-dependent and
-independent activities that is most highly expressed in brain
(Chuang et al., 2002; Hageman et al., 2010). Further, expres-
sion of Mrj is increased in astrocytes from Parkinson’s disease
patients, where it is found to be a component of Lewy bodies
(Durrenberger et al., 2009). Alternative splicing produces two
isoforms (Hanai and Mashima, 2003). DnaJB6a is 36 kDa and
localizes to the nucleus, whereas DnaJB6b is 26 kDa and cytosolic
but translocates to the nucleus in response to cellular stress
(Andrews et al., 2012). What are Mrj’s targets? Mrj suppresses
aggregation and toxicity of several aggregation-prone proteins
including: huntingtin, α-synuclein and parkin (Chuang et al.,
2002; Durrenberger et al., 2009; Hageman et al., 2010; Kampinga
and Craig, 2010; Rose et al., 2011). Possible “client proteins” in
addition to disease-causing proteins include: keratin-intermediate
filaments (Watson et al., 2007), histone deacetylase (HDAC;
Hageman et al., 2010) and the transcription factor, NFATc3 (Dai
et al., 2005). Mrj KO is embryonic lethal in mice due to a failure
of chorioallantoic attachment in placental development (Hunter
et al., 1999). All human mutations causing myopathy are found
in a glycine-phenylaline linker region that follows the amino
terminal J domain and result in a reduction in the inhibition of
protein aggregation (Sarparanta et al., 2012). Furthermore, low
expression of Mrj has been linked to breast cancer (Andrews
et al., 2012). It remains an open question why mutations in
neuronal-enriched Mrj cause myopathy and low levels are linked
to cancer rather than neurodegeneration. Further investigation
is required to understand these somewhat disparate pieces and
develop a clear picture of the neuroprotective actions of Mrj.
It is noteworthy that in the wobbler mouse, an ALS model of
progressive motor neuron degeneration, DnaJB3, which shares
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90% identity with Mrj(DnaJB6), shows reduced expression in the
spinal cord prior to loss of motor neurons (Boillée et al., 2002).
Overlap in Mrj and DnaJB3 expression as well as possible overlap
in DnaJB6/DnaJB3 client proteins remains to be determined.
DNAJC5 (CSPα)
The DnaJC5 gene encodes CSPα, a 35 kDa secretory vesicle
protein. Mutations in DnaJC5, cause adult onset, neuronal ceroid
lipofusinosis (ANCL), a neurodegenerative disorder characterized
by lysosomal accumulation of autofluorescent oxidized lipid and
protein waste, called lipofuscin (Benitez et al., 2011; Nosková
et al., 2011; Velinov et al., 2012). Deletion of leucine 116 (L1164),
or mutation of residue 115 from leucine to arginine (L115R)
results in ANCL which is clinically characterized by anxiety,
depression, speech difficulties, ataxia, myoclonus, involuntary
movements, progressive seizures and dementia. Neuronal ceroid
lipofuscinoses (NCLs) are a heterogeneous group of inherited
lysosomal storage disorders caused by mutations that lead to
accumulation of lipofuscin and loss of neurons (Anderson et al.,
2013). ANCL is unique among NCLs in that it is adult onset
and the only NCL mutations inherited in an autosomal dominant
manner.
What is the physiological function of CSPα? CSPα protects
against synapse loss, however the precise molecular mechanism
underlying neuroprotection is not yet known. In addition to
its N terminal J domain, CSPα bears a hydrophobic region
followed by the distinctive cysteine string region after which
the protein is named. Most of the cysteines are palmitoylated,
which anchors CSPα to the synaptic vesicle membrane. CSPα
is located on synaptic vesicles (Mastrogiacomo et al., 1994),
exocrine vesicles (Braun and Scheller, 1995), and endocrine vesi-
cles (Chamberlain et al., 1996; Brown et al., 1998). At birth,
CSPα KO mice appear normal and around postnatal day 20
develop progressive motor deficits and CNS degeneration, fol-
lowed by early lethality (Fernández-Chacón et al., 2004). The
synapse loss in CSPα null mice is activity-dependent and synapses
that fire frequently are lost first (Schmitz et al., 2006; Garcia-
Junco-Clemente et al., 2010). In Drosophila, CSPα KOs that
survive to adulthood are characterized by uncoordinated move-
ments, shaking, and temperature-sensitive paralysis (Zinsmaier
et al., 1994). What are CSPα’s targets? Presynaptic targets that
demonstrate changes in protein levels early-on in the cascade of
neurodegeneration include SNAP25 (Sharma et al., 2011, 2012),
dynamin1 (Zhang et al., 2012) and BK channels (Kyle et al.,
2013; Ahrendt et al., 2014). Other promising targets include;
voltage dependent Ca2+ channels, heterotrimeric G proteins,
syntaxin and synaptotagmin (Donnelier and Braun, 2014). Which
client proteins are critical for triggering the cascade of events
leading to degeneration and which changes are downstream of
the primary event remains an open question. In addition to
CSPα, CSPβ and CSPγ have been identified in the mammalian
genomes (Fernández-Chacón et al., 2004). While brain expresses
only CSPα, all CSP isoforms are expressed in testis, whereas the
cochlea expresses CSPα and CSPβ (Chandra et al., 2005). In CSPα
KO mice, the redundancy of CSPβ in the ribbon synapses protects
against neurodegeneration in cochlea, however other J proteins
do not protect against the absence of CSPα. Surprisingly, in mice,
transgenic expression of α-synuclein abolishes neurodegenera-
tion caused by deletion of CSPα but its protective mechanism
has not yet been fully elucidated (Chandra et al., 2005). The
L1164 and L115R mutations that result in ANCL cause CSPα
to mislocalize implying both a partial loss of function (at the
synaptic vesicle) and a partial gain of function (at the intracel-
lular site of mislocalization). Although progress has been made,
mislocalization is not sufficient to explain lysosome dysfunc-
tion. There are still gaps in our understanding of the molecular
mechanisms underlying CSPα’s neuroprotection with regards to
synaptic vesicle release and recycling (Rozas et al., 2012; Sharma
et al., 2012).
DNAJC6 (AUXILIN)
Mutations in DnaJC6 (auxilin), a 100 kDa nerve-specific J protein
cause recessive juvenile parkinsonism characterized by early onset
(age 3–18) tremor at rest, bradykinesia, rigidity and postural
instability (Edvardson et al., 2012; Vauthier et al., 2012; Körog˘lu
et al., 2013). The severity and age of onset depends on the
extent of the deletion or reduction in expression of auxilin and
in some cases includes mental retardation, epilepsy and lack of
responsiveness to L-Dopa.
Auxilin is one of the best studied J proteins and its role
in uncoating of clathrin from clathrin-coated vesicles is well
established (Ungewickell et al., 1995; Eisenberg and Greene,
2007). Neurotransmission requires a rapid continuous recycling
of synaptic vesicles. Following fusion, clathrin assembles into
a lattice on the presynaptic plasma membrane and deforms
plasma membrane into a clathrin coated vesicle that is severed
from the membrane by dynamin. After internalization auxilin
binds clathrin and Hsc70 and in a J domain-dependent process
uncoats clathrin to replenish the pool of synaptic vesicles (Morgan
et al., 2001). Unpolymerized clathrin remains in association with
Hsc70 until released by nucleotide exchange factors for additional
rounds of endocytosis (Morgan et al., 2013). The clathrin binding
motif and J domain are located at the C terminus of auxilin
and therefore C terminal truncations are expected to render aux-
ilin incapable of uncoating clathrin thereby impairing synaptic
transmission (Morgan et al., 2001). Extending on these studies,
impaired dopamine receptor recycling may explain the lack of L-
Dopa responsiveness observed in some auxilin mutations. Auxilin
KO mice have a high rate of postnatal mortality and surviving
pups have a low body weight and show recycling and endocytosis
defects (Yim et al., 2010). There is a high homology between
neural-specific auxilin (DnaJC6) and ubiquitous GAK (cyclin G
associated kinase; DnaJC26) with primary differences in the N
terminal domain and GAK is thought to partially compensate for
auxilin deletion. Interestingly, genome wide association studies
have linked DnaJC26 (GAK) to Parkinson’s disease susceptibility
(Li et al., 2012).
DNAJC13 (RME-8 RECEPTOR MEDIATED ENDOCYTOSIS)
Mutation of DnaJC13 (RME-8 receptor mediated endocytosis 8)
a 220 kDa J protein (Asn855Ser) cause adult onset autosomal-
dominant Parkinson disease (Vilariño-Güell et al., 2014). Orig-
inally discovered in Saskatchewan, onset of disease is between
59 and 85 years and is characterized by slowly progressive
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tremor, rigidity, bradykinesia and roughly half of the Lewy
body inclusions are immunoreactive for DnaJC13. Interestingly,
DanJC13 mutation (Ala2057Ser) has also been linked to Tourette
syndrome/chronic tic phenotype in patients of European ancestry
(Sundaram et al., 2011).
RME-8 was first identified in a screen for endocytotic defects
in C. elegans (Zhang et al., 2001) and was subsequently shown
to have a role in endocytosis in Drosophila (Chang et al., 2004)
and endosomal function in mammals (Girard et al., 2005).
Surprisingly, Rme-8 which bears a central J domain, is widely
expressed but not especially abundant in brain (Girard et al.,
2005). Rme-8 interacts with retromer (Popoff et al., 2009) and
WASH complexes (Freeman et al., 2014) and loss of RME-
8 disrupts cation independent-mannose-6-phosphate receptor
and epidermal growth factor receptor trafficking (Girard and
McPherson, 2008; Popoff et al., 2009). There are numerous gaps
in our understanding of how disruption of normal Rme-8 func-
tion in endosomal recyclying causes Parkinson disease.
DNAJC19 (TIM14 MITOCHONDRIAL IMPORT INNER
MEMBRANE TRANSLOCASE SUBUNIT 14)
Mutation of DnaJC19 (Tim14 or Pam 18), an 18 Kda J protein,
cause early-childhood-onset (before 3 years) recessive dilated
cardiomyopathy and cerebellar ataxia (Davey et al., 2006; Sparkes
et al., 2007; Ojala et al., 2012). Originally identified in Alberta
Dariusleut Hutterites, DnaJC19 mutations are clinically charac-
terized by raised levels of 3-methylglutaconic acid, a readout of
mitochondrial distress, dilated cardiomyopathy, prolongation of
the QT interval in the electrocardiogram and cerebellar ataxia
(Davey et al., 2006).
DnaJC19 is a transmembrane component of the TIM23 mito-
chondria import machinery that delivers nuclear encoded pro-
teins to the mitochondrial matrix in an ATP dependent manner
(Sinha et al., 2014). DnaJC19 activates mortalin, the mtHsp70
ATPase, and activation is counteracted by MAGMAS, a protein
that contains a C-terminal J-like domain that lacks the HPD motif
required to recruit and activate the Hsc70 ATPase activity. There
are multiple mitochondrial J proteins and our understanding of
the differences in function and specificity remains limited. Clearly,
DNAJC19 and another mitochondrial J protein, DNAJC15, are
not redundant as DnaJC15 does not rescue DnaJC19 mutations
that lead to dilated cardiomyopathy and cerebellar ataxia. This
underscores the importance of identifying the diverse disease
modifying pathways of mitochondrial J proteins.
DNAJC29 (SACSIN)
Mutations in DnaJC29 (sacsin), a 521 kDa J protein, cause
early-childhood-onset (age 1–2 years), recessive spastic ataxia of
Charlevoix-Saguenay (ARSACS; Bouchard et al., 1978). Originally
discovered in Quebec in 1978 (Bouchard et al., 1978), we now
know that >100 different mutations in DnaJC29 mutation exist
worldwide (Engert et al., 2000; Thiffault et al., 2013). ARSACS is
clinically characterized by unsteady gait, spasticity, ataxia, muscle
atrophy, due to progressive cerebellar atrophy and peripheral neu-
ropathy. Quebec patients never walk properly and are wheelchair-
bound on average by 41 years with life expectancy approximately
51 years. Outside of Quebec, mild ARSACS with onset delayed
until later childhood and early 20’s or severe ARSACS with mental
retardation is also found (Baets et al., 2010; Thiffault et al., 2013).
Deposits of lysosome derived oxidized lipid and protein waste,
called lipofuscin, are found in cerebellar cortical neurons or skin
(Stevens et al., 2013), somewhat reminiscent of DnaJC5 mutations
that cause ANCL.
Sascin is the largest J protein, bearing C termini J domain,
an N-terminal ubiquitin-like domain and a higher eukaryotic
and prokaryotic nucleotide binding domain (HEPN; Parfitt et al.,
2009; Kozlov et al., 2011). Sacsin is predominantly cytosolic with
a mitochondria component, it interacts with dynamin-related
protein 1, a GTPase required for mitochondrial fission (Kozlov
et al., 2011; Girard et al., 2012; Thiffault et al., 2013). Knockdown
of sacsin in SH-SY5Y cells results in an overly interconnected and
functionally impaired mitochondrial network with mitochondria
accumulating in the soma and proximal dendrites (Girard et al.,
2012). Sacsin KO mice display age-dependent neurodegeneration
of cerebellar Purkinje cells most likely due to defects in mitochon-
drial proteostasis (Girard et al., 2012). Much work will be needed
to untangle the complexities of sacsin mutations and ensuing
neurodegeneration.
FUTURE PROSPECTS
Independent threads have recently begun to provide insight into
how select J proteins in the protein quality machinery monitor
and adjust proteotoxic imbalances in order to maintain neural
function. Many knowledge gaps in our understanding of the func-
tionality of specific J proteins exist. It remains to be seen whether
identification of further human mutations will yield insights into
the biological roles of J proteins. Ultimately, systematic analysis
of the mechanisms by which J proteins facilitate proteostasis will
enable us to develop novel therapeutic agents and re-purpose
drugs currently used for other indications.
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